Archived TB Guidelines

Archived TB Guidelines MMWR 
Title Format Date Published
Notice to Readers: Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosispdf icon
MMWR 2008; 57 (No. 4, 98)
PDFpdf icon
(268 KB)
01/2008
Errata: Treatment of Tuberculosis
MMWR 2005; 52 (RR–11)
N/A 1/2005
Treating Opportunistic Infections Among HIV–Infected Adults and Adolescents

MMWR 2004; 53 (RR15)

N/A 12/2004
Treating Opportunistic Infections Among HIV–Exposed and Infected Children

MMWR 2004; 53 (RR14)

N/A 12/2004
Notice to Readers: Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV–Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors

MMWR 2004; 53 (No. 2)

PDFpdf icon
(346 KB)
1/2004
Treatment of Tuberculosis

MMWR 2003; 52 (No. RR–11) : Errata :TB Treatment Guidelines in PDA Format

N/A 6/2003
Guidelines for Using the QuantiFERON®–TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection 
MMWR
 2002; 51 (12/18/02)
PDFpdf icon
(398 KB)
1/2003
Public Health Dispatch: Update:
Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide Treatment for Latent Tuberculosis Infection
MMWR
2002; 51 (No. 44)
PDFpdf icon
(1.7 MB)
11/2002
Guidelines for Preventing Opportunistic Infections Among HIV–Infected Persons — 2002

MMWR 2002; 51 (No. RR–8)

N/A 6/2002
Preventing and Controlling Tuberculosis Along the U.S.–Mexico Border Work Group Report

MMWR 2001; 50 (No. RR–1)

N/A 1/2001
Update: Nucleic Acid Amplification Tests for Tuberculosis

MMWR 2000; 49 (No. 26)

N/A 7/2000
Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors

MMWR 2000: 49 (No. 9)

N/A 3/2000
Diagnostic Standards and Classification of Tuberculosis in Adults and Childrenexternal icon
Am J Respir Crit Care Med 2000; 161
PDFexternal icon
168 KB)
7/1999
Prevention and Treatment of Tuberculosis among Patients Infected with Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations
MMWR 1998; 47 (No. RR–20)
PDF
(743 KB)
10/1998
Anergy Skin Testing and Preventive Therapy for HIV–Infected Persons: Revised Recommendations
MMWR
1997; 46 (No. RR–15)
PDFpdf icon
(1.8 MB)
9/1997
Nucleic Acid Amplification Tests for Tuberculosis

MMWR 1996; 45 (No. 43)

N/A 11/1996
Prevention and Control of Tuberculosis in Correctional Facilities (ACET)
MMWR  1996; 45 (No. RR–8)
N/A 6/1996
Screening for Tuberculosis and Tuberculosis Infection in High–Risk Populations (ACET)
MMWR
1995; 44 (No. RR–11)
PDFpdf icon
(358 KB)
9/1995
Guidelines for Preventing the transmission of Mycobacterium tuberculosis in Health–Care Facilities, 1994pdf icon
MMWR
1994; 43 (No. RR–13)
PDFpdf icon
(8.5 MB)
10/1994
Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence

MMWR 1993; 42 (No. RR-4)

N/A 4/1993
Prevention and Control of Tuberculosis in Migrant Farm Workers (ACET)
MMWR
1992; 41 (No. RR–10)
N/A 6/1992
National Action Plan to Combat Multidrug–Resistant Tuberculosis
MMWR
1992; 41 (RR–11)
N/A 6/1992
Management of Persons Exposed to Multidrug–Resistant Tuberculosis
MMWR
1992; 41 (RR–11)
N/A 6/1992
Prevention and Control of Tuberculosis in U.S. Communities with At–Risk Minority Populations (ACET)
MMWR
1992; 41 (No. RR–5)
N/A 4/1992
Prevention and Control of Tuberculosis Among Homeless Persons (ACET)
MMWR
1992; 41 (No. RR–5)
N/A 4/1992
Prevention and Control of Tuberculosis in Facilities Providing Long–Term Care to the Elderly (ACET)
MMWR
1990; 39 (RR–10)
N/A 7/1990
A Strategic Plan for the Elimination of Tuberculosis in the United States
MMWR
1989; 38 (S–3).
N/A 4/1989